What sets high-performing healthcare launch teams apart?
In the fast-paced world of pharmaceutical, biotech, and consumer healthcare launches, the difference between success and struggle often comes down to the strength of the launch team. A cohesive, focused, and well-prepared team can drive a launch forward with confidence, while a team lacking alignment and strategic clarity may find itself facing unnecessary obstacles.
From our extensive experience working with launch teams globally, we have identified the characteristics that distinguish high-performing teams from those that encounter challenges. Successful teams establish a clear vision, ambition, and set of priorities to guide their launch strategy. They believe in the value and impact of the medicine they are introducing, ensuring their approach remains authentic and patient-centred. They also challenge their global and regional colleagues to deliver practical, timely outputs that drive momentum forward.
Rather than relying solely on past experience, these teams validate previous learnings within the current context, ensuring their strategies remain relevant. They dedicate time to defining a clear team charter and governance framework, reinforcing accountability and alignment. By studying recent launch successes and failures, they refine their approach and stay ahead of industry trends. Feedback from payers, prescribing physicians, and patients is integrated consistently, ensuring their strategy remains well-informed and adaptable.
A strong strategic and tactical launch plan underpins their success, complete with measurable pre- and post-launch KPIs. They secure active support from the General Manager, who plays a key role in resolving challenges and ensuring resources are available. Above all, they bring energy and commitment to their work, driven by a passion for launching innovative solutions that make a meaningful impact.
The real-world impact of a high-performing launch team
The measurable business impact of a well-structured, motivated launch team is evident in some of the most successful pharmaceutical launches. In a recent case study, a global biotech firm preparing to launch a first-in-class oncology treatment implemented a cross-functional team model with clear governance and well-defined roles. By securing executive support early on, aligning incentives across global and local teams, and ensuring frequent communication with market access stakeholders, the company achieved an accelerated market entry, securing reimbursement within six months in key territories.
Another example comes from a mid-sized pharmaceutical company launching a rare disease therapy. Initially, the team faced misalignment on pricing and access strategy between the global and local affiliates. Establishing regular alignment meetings, bringing in external industry experts to refine their access strategy, and incorporating real-time insights from patient advocacy groups enabled them not only to improve their launch execution but also to strengthen long-term relationships with key stakeholders. The result was a 40% higher-than-anticipated uptake within the first year.
Strengthening your launch readiness
If your team is preparing for an upcoming launch, now is the time to assess its readiness. A strong vision, clear purpose, and well-defined ways of working can make the difference between a launch that struggles and one that excels. Teams that take a proactive approach by addressing potential gaps before launch execution often achieve stronger commercial outcomes and greater long-term success.
To gain deeper insights into your team’s preparedness, explore our launch excellence tool, LExLevel Pulse. This self-assessment provides valuable benchmarks and recommendations to help you refine your approach. The tool has been used by leading pharmaceutical companies to identify key areas of improvement and build actionable plans for launch success.
The impact of a well-structured and highly motivated launch team has been demonstrated time and again across therapy areas and markets. If you would like to discuss how to optimise your launch team’s effectiveness, get in touch with us today. Learn more about our approach to launch excellence by visiting our dedicated services page.
Discover a list of the good and the bad below:
The good:
- Have a clear vision, ambition and priorities for a successful launch
- Have an authentic belief in the innovative medicine they are bringing to market
- Challenge their global / regional colleagues to deliver practical outputs on time
- Incorporate learnings from their past experience, but validate them with current context
- Invest time in building a clear team charter and governance
- Have studied recent launch awards and failures intensively to upskill on launch
- Have listened carefully and consistently to feedback from payers, physicians likely to prescribe, and patients
- Have created a detailed strategic and tactical launch plan with measurable pre- and post-launch KPIs
- Have the emphatic and active support of the GM to resolve issues and provide resources
- Are not afraid to go the extra mile day after day because they love their launch job!
The not so good:
- Don’t have a clearly appointed launch team with incentives aligned to launch success
- No clear budget allocated for pre- and post-launch activities
- Lack of global senior management commitment to launch decisions and resourcing
- Lack of internal alignment on pricing, value and access strategy at global and local level
- Launch leader has other priorities
- Launch forecast is not endorsed by local launch teams or industry analysis
- Misalignment between launch ambition / forecast and resource allocation
- Minimal Key Opinion Leader and Patient Advocacy Group input into commercialisation and evidence plan
- Limited input from expert industry agencies on access, promotion, MedEd, PR
- No best practice sharing across countries on prescriber, patient, competitor response to launch
Contact us
